Breaking News
Translate

World’s top cardiologists attend Pfizer’s cardiovascular summit

By Sola Ogundipe
Renowned cardiology expert and Senior lecturer at the Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Prof. Lansberg Peter Jan, as well as Prof. Vincent Idemyor, a Nigerian professor of Clinical Pharmacology and Medicine at the University of Illinois, USA, are among leading cardiologists, nephrologists (kidney specialists) and other experts in the study and management of heart diseases expected at the 2nd Pfizer’s Cardiovascular Summit holding tomorrow in Lagos.

A release signed by the company’s Country Manager for the Nigeria, East Africa Region (NEAR) and Chief Executive Officer, Pfizer Specialties Nigeria Limited, Dr. Enrico Liggeri, said the experts will join their Nigerian counterparts at the Summit – a scientific forum for dissemination of information on cardiovascular diseases (CVDs), to deliberate on current issues and challenges of CVD globally, and particularly in Africa and Nigeria.

Also expedted on the panel are Prof. Basden Onwubere a professor of Medicine and Cardiologist at the University of Nigeria Teaching Hospital (UNTH), Enugu; Prof. Solomon Kadiri, a Consultant Nephrologist at the University College Hospital (UCH), Ibadan,; Professor Solomon Danbauchi, a Consultant Cardiologist and Head, Department of Medicine, Ahmadu Bello University Teaching Hospital (ABUTH), Zaria and Dr. Amam Mbakwem, a Consultant Cardiologist at the College of Medicine, University of Lagos.

“As the world’s biggest pharmaceutical company, Pfizer is concerned about the increase of cardiovascular diseases in Africa, including Nigeria . The goal of the Summit is not only to draw attention to this worrisome trend but also to ensure that CVDs are given due attention by the medical community so that more Nigerians can be saved from the fatal complications associated with the disorders.

According to Liggeri: “One of the common risk factors for CVD, Hypertension is now a global epidemic affecting no fewer than 30 million Nigerians suffer from this condition which is a main risk factor for stroke, cardiac (heart) failure, renal (kidney) failure and coronary heart disease.

“These are facts we believe experts need to work with and come up with appropriate strategies for the control and management of CVDs in Nigeria.”

Pfizer, for many years, has devoted large resources to provide patients and doctors with innovative molecules to manage the burden of CVDs. Pfizer is the original manufacturer of Norvasc, the first brand of amlodipine besylate and world’s most prescribed brand name high blood pressure medicine as well as Lipitor, the number one medicine sold globally for the lowering of blood cholesterol level.


Disclaimer

Comments expressed here do not reflect the opinions of vanguard newspapers or any employee thereof.